Religare Enterprises Limited has announced a significant change in its senior management team with the resignation of Dr. Richa Mishra from her position as Director & Group Head – Human Resources. The company made this disclosure on April 07, 2026, in compliance with regulatory requirements under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Management Transition Details

The resignation became effective from the close of business hours on April 06, 2026. Dr. Mishra was designated as Senior Managerial Personnel of the company in her role as Director & Group Head – Human Resources.

Regulatory Compliance

Religare Enterprises filed the mandatory disclosure with both the National Stock Exchange of India Limited and BSE Limited. The company's scrip symbol is RELIGARE on NSE and scrip code is 532915 on BSE. The disclosure was made pursuant to Regulation 30 of SEBI Listing Regulations and Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Resignation Letter

In her formal resignation letter dated April 06, 2026, Dr. Mishra expressed gratitude for her professional growth during her tenure at Religare Enterprises. She emphasized that her time at the company allowed her to develop professionally and thanked the organization for the opportunity provided to her.

Company Information

Religare Enterprises Limited operates with CIN L74899DL1984PLC146935. The company maintains its registered office at First Floor, Office No. 101, 2E/23, Jhandewalan Extension, New Delhi – 110055, while its corporate office is located at 2nd Floor, Plot A-3,4 & 5, Club 125, Tower B, Sector -125, Noida – 201301, Uttar Pradesh.

The disclosure was signed by Anuj Jain, Company Secretary & Compliance Officer, and submitted with all required annexures as per regulatory guidelines. The company noted that the designation "Director" mentioned refers to an internal organizational title and does not imply a Director as defined under the Companies Act, 2013.

Religare Enterprises Limited has granted 22,692 stock options to eligible employees under its Employee Stock Option Plan 2019, as approved by the company's Nomination and Remuneration Committee on March 30, 2026. This employee incentive initiative demonstrates the company's commitment to aligning workforce interests with long-term organizational growth.

Stock Option Grant Details

The comprehensive stock option grant encompasses several key parameters designed to provide structured employee benefits over an extended period.

Vesting Schedule and Timeline

The stock options follow a structured five-year vesting schedule, ensuring gradual benefit realization and employee retention. The vesting occurs in equal annual installments, with each tranche representing 20% of the total grant.

The first vesting installment will occur upon completion of one year from the grant date, establishing a clear timeline for employee benefit realization.

Exercise Terms and Regulatory Compliance

Employees will have up to eight years from the respective vesting dates to exercise their stock options, providing flexibility in timing their equity participation. The scheme operates in full compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, having received approval from both the Board of Directors and shareholders.

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency in its employee benefit programs. As the options have not yet been exercised, no diluted earnings per share impact has occurred at this time.

Strategic Employee Incentive Initiative

This stock option grant represents Religare Enterprises' ongoing effort to attract and retain talent through equity-based compensation. The structured vesting schedule and extended exercise period provide employees with long-term incentive alignment, encouraging continued contribution to company success over multiple years.